Bio Green Med Solution (BGMSP) Research & Development (2010 - 2025)

Bio Green Med Solution (BGMSP) has reported Research & Development for 16 consecutive years, with -$47000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Research & Development fell 105.34% year-over-year to -$47000.0 in Q4 2025; TTM through Dec 2025 was $848000.0, a 87.26% decrease from a year earlier, with the FY2025 full-year figure at $848000.0, down 87.26% from the prior year.
• Research & Development was -$47000.0 for Q4 2025 at Bio Green Med Solution, down from $5000.0 in the prior quarter.
• Over five years, Research & Development peaked at $6.7 million in Q4 2022 and troughed at -$47000.0 in Q4 2025.
• A 5-year average of $3.1 million and a median of $3.7 million in 2021 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 264.93% in 2021 and tumbled 105.34% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $4.3 million in 2021, then soared by 54.5% to $6.7 million in 2022, then tumbled by 47.51% to $3.5 million in 2023, then tumbled by 74.99% to $880000.0 in 2024, then sank by 105.34% to -$47000.0 in 2025.
• The last three Research & Development figures came in at -$47000.0 (Q4 2025), $5000.0 (Q3 2025), and $68000.0 (Q2 2025), per Business Quant data.